Coeliac disease is associated with an increased risk of small bowel lymphoma and adenocarcinoma. ' The earliest association between coeliac disease and malignant lymphoma was reported by Fairley and Mackie (1937) .2 Histological stains enabled the identification of T-cell lymphoma, now designated as enteropathyassociated T-cell lymphoma (EATL) as the most common neoplasm (96%) associated with coeliac disease in one series,3 and B-cell lymphoma accounting for the remaining 4%. The cause for this association remains uncertain. HLA genotyping has indicated that lymphoma is more common in DQA1*0501, DQB1*0201 individuals.4 Small bowel malignancy typically occurs in the fifth to seventh decades of life. Recent studies using population screening have provided an estimate of prevalence of coeliac disease (in particular, 1 On admission, antibodies to endomysium and tissue transglutamase (31Eu/ml, normal: 0-25) were positive. Endomysial antibodies were measured by immunofluorescence with a titre 1:5 or greater taken as positive, and tissue transglutamase was measured by immunosorbent assay (ELISA). OGD was performed, and duodenal biopsy showed partial villous atrophy. Colonoscopy showed a large flat ulcer at the distal transverse colon and biopsies revealed mucosal inflammation with no evidence of malignancy. He was commenced on a gluten-free diet. Ten days later, he developed two large episodes of bright red bleeding per rectum which required blood transfusion; however he continued to bleed and 48 hours later, laparotomy was undertaken. At laparotomy, the ulcerated area of colon was identified and transverse colectomy was performed. It was also noted that a segment of ileum was thickened. No procedure was carried out on the small bowel. Histological examination confirmed an ulcer with appearances suggestive of malignant lymphoma. The lymphoma was covered by thick inflammatory exudates; probably explaining the initial benign colonoscopic biopsies. Some of the cells were positive for CD68. The majority of cells did not stain for either B-or T-cell markers. Therefore, it was regarded as a non-B, non -T cell lymphoma. Due to the appearance of the small intestines at laparotomy, a small bowel series was carried out which was normal. Postoperatively, he became very depressed and his appetite waned and he was commenced on enteral feeding. Three weeks later he had a sudden deterioration and died due to pneumonia. Autopsy failed to show any further evidence of systemic lymphoma.
DISCUSSION
Lymphoma accounts for approximately 0.2 to 0.6% of large bowel malignancies.8 The mean age of presentation is 55 years with a male preponderance.9 So far, two risk factors have been identified: inflammatory bowel disease'0 and immunosuppression (post-kidney transplant, HIV, immune disorder).11 12 In coeliac disease a lymphocytic infiltrate develops in the gastric and colonic mucosa;'3 to date no association has been described between coeliac disease and colonic lymphoma. Immunological changes (rises in CD3+ and CD25+ lymphocytes and proinflammatory cytokines) have been noted in rectal mucosa ofuntreated coeliac patients, after a gluten challenge in the form of gluten enema had been given. 14 As described above, microscopic inflammation is present in the colon of those with coeliac disease. It is possible that such inflammation could predispose to malignant transformation. As yet, this hypothesis remains untested. Colonic adenocarcinoma has been described in patients with coeliac disease. ' Prognostic data of primary colorectal lymphoma in the literature is scarce. Although histological stage significantly correlates with survival, in several series different pathological classifications were used. In another series, the presence of tumour cell MT2 immunoreactivity appeared to be a better determinant of prognosis than histological grade.'7 Surgical resection is recommended for localised colo-rectal lymphoma as it may provide important prognostic information, offer a chance for cure, with or without adjuvant therapy, and prevent surgical complications."8 The value of chemotherapy, either alone or as adjuvant therapy for colonic carcinoma has not been prospectively evaluated. Radiotherapy and/or chemotherapy may also be of value for lymphoma with advanced stage and high-grade lymphomas. 7 
CONCLUSION
We have highlighted an uncommon disease occurring in the context of coeliac disease. This is the first report of coeliac disease in association with solitary colonic lymphoma, although there may be a possibility of the tumour occurring coincidentally in a patient with coeliac disease. A recent retrospective study in Northern Ireland had demonstrated that a third of patients with apparently spontaneous small bowel lymphomas had unrecognised coeliac disease.'9 This case may suggest that a similar search for coeliac disease in patients with colonic lymphoma might be appropriate.
